We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 285 start-ups with an aggregate funding of $5.7b. The average funding per company in this subset is $82.6m.
Last update to the database: Feb 18, 2025. See changelog.
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.
5
Funding Rounds
$263.1m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
3
Funding Rounds
$21.5m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
5
Funding Rounds
$111.8m
Money raised
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
2
Funding Rounds
$120.0m
Money raised
Prellis Biologics is developing technology to build transplantable human organs and tissues.
6
Funding Rounds
$88.0m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$190.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
8
Funding Rounds
$117.5m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
2
Funding Rounds
$13.8m
Money raised
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
1
Funding Rounds
Silicon Valley-based genetic engineering startup.
8
Funding Rounds
$459.7m
Money raised
Bionic is a company founded in 2019 by Idan Ninyo.
2
Funding Rounds
$82.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
Company manufacturing 3d printed pharmaceuticals based in San Francisco, CA
4
Funding Rounds
$30.0m
Money raised
SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.
1
Funding Rounds
$10.5m
Money raised
Biological micro-pancreas for insulin-dependent diabetics company
4
Funding Rounds
$5.1m
Money raised
Integrated DNA Technologies is a Coralville, Iowa-based company founded in 1987.
1
Funding Rounds
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
3
Funding Rounds
$183.9m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
3
Funding Rounds
$109.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
5
Funding Rounds
$425.0m
Money raised
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
5
Funding Rounds
$14.5m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
Allevi, formerly known as BioBots, is a technology company making 3 dimensional bioprinters and bioinks for their printers. The company was founded in 2014 and located in Philadelphia, Pennsylvania.
1
Funding Rounds
$2.0m
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
A biotechnology company with a focus on developing medical solutions with biomaterial. It was founded in 2015 and is located in Durham, North Carolina.
2
Funding Rounds
$6.2m
Money raised
Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.
1
Funding Rounds
$3.9m
Money raised
Celdara Medical is a biotechnology company helping turn academic innovations into medical products.
1
Funding Rounds
$1.7m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
A biotechnology company using tissue engineering to create biomaterials for repairing and regenerating the human body.
1
Funding Rounds
$13.2m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
1
Funding Rounds
$12.8m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
2
Funding Rounds
$82.0m
Money raised
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
2
Funding Rounds
$177.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$7.0m
Money raised
Coave Therapeutics is a genetic medicines developer founded in 2014.
6
Funding Rounds
$94.2m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
3
Funding Rounds
$73.4m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
11
Funding Rounds
$37.9m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
9
Funding Rounds
$59.1m
Money raised
Trailhead Biosystems is a biotechnology company developing cell therapy products.
3
Funding Rounds
$17.2m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
1
Funding Rounds
$15.0m
Money raised
A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.
1
Funding Rounds
$2.0m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
4
Funding Rounds
$72.3m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
Asimov is a startup that programs living cells with genetic circuits.
1
Funding Rounds
$4.7m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
2
Funding Rounds
$33.9m
Money raised
Embody, Inc. is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address unmet needs in soft tissue restoration and regeneration.
3
Funding Rounds
$15.4m
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
4
Funding Rounds
$6.0m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
2
Funding Rounds
$2.6m
Money raised
Mekonos is a company that creates cell-engineering platforms
3
Funding Rounds
$31.0m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
1
Funding Rounds
$71.5m
Money raised
TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.
4
Funding Rounds
$1.4m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$200.0m
Money raised
StemBioSys is a biotechnology company developing regenerative medicines using stem cells.
1
Funding Rounds
$1.5m
Money raised
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia.
3
Funding Rounds
$70.8m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
8
Funding Rounds
$84.5m
Money raised
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013.
2
Funding Rounds
$122.8m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$35.0m
Money raised
Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies
1
Funding Rounds
$22.0m
Money raised
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
1
Funding Rounds
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
4
Funding Rounds
$343.1m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Universal Cells is a biotechnology company developing regenerative medicine using stem cells.
1
Funding Rounds
$60.0k
Money raised